Peer Comparison Feedback for Surgery

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
US Anesthesia Partners, Dallas, TX
Surgery+1 More
Peer Comparison Feedback - Behavioral
Eligibility
65+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will test whether peer comparison feedback or mailed informational letters to patients can help reduce the number of older surgical patients in the US who receive benzodiazepines during anesthesia care. The trial will compare the use of Peer Comparison Feedback to no treatment in patients undergoing surgery. All patients in the trial will receive Peer Comparison Feedback. There will be no placebo group. This is a Phase III clinical trial.

Eligible Conditions

  • Surgery
  • Aging

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: Up to 30 days after surgery

Intraoperative period
Benzodiazepine administration rate
Day 30
Hospital length of stay
Day 30
Patient satisfaction
Postoperative Delirium
Postoperative pulmonary complications

Trial Safety

Safety Progress

1 of 3

Trial Design

4 Treatment Groups

Control
1 of 4
Patient Informational Letter
1 of 4
Peer Comparison Feedback plus Patient Informational Letter
1 of 4
Peer Comparison Feedback
1 of 4
Active Control
Experimental Treatment

225000 Total Participants · 4 Treatment Groups

Primary Treatment: Peer Comparison Feedback · No Placebo Group · N/A

Patient Informational Letter
Behavioral
Experimental Group · 1 Intervention: Patient Informational Letter · Intervention Types: Behavioral
Peer Comparison Feedback plus Patient Informational LetterExperimental Group · 2 Interventions: Peer Comparison Feedback, Patient Informational Letter · Intervention Types: Behavioral, Behavioral
Peer Comparison Feedback
Behavioral
Experimental Group · 1 Intervention: Peer Comparison Feedback · Intervention Types: Behavioral
ControlNoIntervention Group · 1 Intervention: Control · Intervention Types:

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: up to 30 days after surgery
Closest Location: US Anesthesia Partners · Dallas, TX
Photo of Dallas 1Photo of Dallas 2Photo of Dallas 3
N/AFirst Recorded Clinical Trial
1 TrialsResearching Surgery
0 CompletedClinical Trials

Who is running the clinical trial?

Donaghue Medical Research FoundationOTHER
22 Previous Clinical Trials
60,356 Total Patients Enrolled
University of PennsylvaniaLead Sponsor
1,797 Previous Clinical Trials
35,883,062 Total Patients Enrolled
7 Trials studying Surgery
2,327 Patients Enrolled for Surgery
US Anesthesia PartnersUNKNOWN
Mark D Neuman, MD, MScPrincipal InvestigatorUniversity of Pennsylvania
1 Previous Clinical Trials
1,848 Total Patients Enrolled

Eligibility Criteria

Age 65+ · All Participants · 1 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.